| Financial Year |
March 31 2023 |
| Monetary Funds |
1,030,789,692.31 |
| Held-for-trading Financial Assets |
30,000,000.00 |
| Notes Receivable |
4,599,163.25 |
| Accounts Receivable |
965,558,644.73 |
| Advances to Suppliers |
290,956,662.86 |
| Other Receivables |
60,284,430.48 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
473,489,705.12 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
81,515,328.99 |
| Total Current Assets |
2,937,570,457.74 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
24,991,124.52 |
| Investment Properties |
40,621,980.24 |
| Fixed Assetes |
787,467,538.48 |
| Under-construction Projects |
162,455,013.38 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
79,051,588.23 |
| R&D expenses |
-- |
| Goodwill |
330,727,970.76 |
| Long-Term Deferred and Prepaid Expenses |
8,986,216.75 |
| Deferred Income Tax Assets |
41,639,051.49 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
1,676,333,820.86 |
| Total Assets |
4,613,904,278.60 |
| Short-Term Loans |
315,379,440.28 |
| Trading Financial liabilities |
-- |
| Notes Payable |
53,311,135.00 |
| Accounts Payable |
984,385,458.86 |
| Accounts Received In Advance |
26,620,228.69 |
| Employee Compensation Payable |
68,070,896.22 |
| Taxes Payable |
17,532,122.47 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
99,342,874.69 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
29,373,032.97 |
| Other Current Liabilities |
23,410,669.52 |
| Sub-Total of Current Liabilities |
1,952,756,075.79 |
| Long-term Loans |
118,166,458.27 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
74,635.04 |
| Special Payable |
-- |
| Estimatied Liabilities |
12,902,260.08 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
186,636,107.83 |
| Total Liabilities |
2,139,392,183.62 |
| Paid-In Capital(Or Share Stock) |
810,991,332.00 |
| Capital Surplus |
1,571,281,880.13 |
| Surplus Reserve |
73,710,096.69 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-68,574,217.06 |
| Minority Stockholder's Interest |
74,777,275.25 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,399,734,819.73 |
| Owner's Equity（Stockholder's Equity） |
2,474,512,094.98 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,613,904,278.60 |
